Pay in 4 interest-free payments of $5.49 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Key Takeaways GLP-1 receptor agonists (GLP-1RAs) are a critical advancement in managing type 2 diabetes and obesity, offering significant benefits in blood sugar control and weight loss, but differ in their mechanisms of action, dosing schedules, and side effects
Persistent cases sometimes improve with dose reduction
Your provider may suggest tapering so your body can adjust gently
Blood sugar levels spike: As Ozempic regulates blood sugar levels, discontinuing the medication will result in a rapid change, which could worsen the effects of type 2 diabetes, leading to potentially severe health consequences
In fact, some SSRIs cause weight gain, so adding a GLP-1 agonist may help counteract that effect
